S M T W T F S
 
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
 
 
 
 
 
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
 
25
 
26
 
27
 
28
 
29
 
30
 
 
 
 
 
 
 

Here's Why Invitae Jumped 13% in September

DATE POSTED:October 11, 2018

Shares of Invitae (NYSE: NVTA) rose 13% last month, according to data provided by S&P Global Market Intelligence. There wasn't any specific news to spur shares higher, but investors and analysts have been very pleased with recent developments. In fact, the company's market valuation more than tripled from below $300 million in early May to over $900 million -- and briefly over $1.2 billion -- in September.

That had a lot to do with second-quarter and first-half 2018 operating results released in early August. Invitae delivered year-over-year revenue growth of 172% in the first six months of 2018, which makes it one of the fastest-growing businesses in the genetic testing and precision medicine space.

But as a nearly 19% drop since the beginning of October shows, investors will continue to be exposed to higher-than-average volatility with Invitae stock. Here's why.

Continue reading